Table 2

Associations of cholesterol and lipoproteins with MMP-7 and SP-A

% change in MMP-7 (95% CI)*p Value% change in SP-A (95% CI)*p Value
Total cholesterol−0.01 (−2.25 to 2.28)0.991.43 (−2.95 to 6.00)0.52
HDL-C, mg/dL−3.53 (−6.07 to −0.93)0.008−6.37 (−11.13 to −1.35)0.01
LDL-C, mg/dL0.35 (−2.55 to 1.89)0.763.44 (−0.98 to 8.05)0.13
Triglycerides2.81 (0.30 to 5.37)0.03−3.11 (−7.69 to 1.70)0.20
Large HDL, 9.4–14 nm−4.10 (−7.26 to −0.84)0.01−14.39 (−19.82 to −8.59)<0.001
Medium HDL, 8.2–9.4 nm−4.92 (−7.61 to −2.14)<0.001−1.67 (−7.06 to 4.02)0.56
Small HDL, 7.3–8.2 nm−5.32 (−8.03 to −2.53)<0.001−8.23 (−13.31 to −2.86)0.003
Large LDL, 20.5–23 nm−4.86 (−7.50 to −2.15)<0.001−0.68 (−6.02 to 4.96)0.81
Small LDL, 18–20.5 nm−1.51 (−4.73 to 1.81)0.37−7.35 (−13.18 to −1.12)0.02
Apolipoprotein A-1−2.83 (−5.32 to −0.27)0.03−4.79 (−9.56 to 0.12)0.06
Apolipoprotein B1.74 (−0.64 to 4.18)0.151.51 (−3.06 to 6.36)0.52
  • Solid lines separate distinct models. Each model includes all exposure variables listed and is additionally adjusted for age, gender, race/ethnicity, body mass index, smoking status, cigarette pack-years, presence of coronary artery calcium, statin use, interleukin 6 and C reactive protein.

  • *Reported per SD in each exposure variable.